Search Results 1491-1500 of 33424 for oral

  1. Ombitasvir, paritaprevir, ritonavir and dasabuvir (oral route) - Side effects & dosage - Mayo Clinic

    For oral dosage form (tablets):. For chronic hepatitis C virus infection, with or without ribavirin: Adults—2 pink tablets once a day (taken in the morning) ...

  2. Carisoprodol, aspirin, and codeine (oral route) - Side effects & dosage - Mayo Clinic

    For relaxing muscles: For oral dosage form (tablets):. Carisoprodol, aspirin, codeine: Adults—1 or 2 tablets 4 times a day for ...

  3. Drugs and Supplements that Start with I - Mayo Clinic

    Im · Imaavy. Also known as. Nipocalimab-aahu (intravenous route) · Imatinib (oral route) · Imbruvica. Also known as. Ibrutinib (oral route) · Imcivree. Also known ...

  4. Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin ...

  5. A Study to Evaluate the Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia with Lewy Bodies - Mayo Clinic

    A Study to Evaluate the Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia with Lewy Bodies · Overview · Participation eligibility.

  6. Aliskiren and hydrochlorothiazide (oral route) - Side effects & dosage - Mayo Clinic

    For oral dosage form (tablets):. For high blood pressure: Adults—At first, one tablet containing 150 milligrams (mg) of aliskiren and 12.5 mg of ...

  7. Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS - Mayo Clinic

    The purpose of this study is to evaluate and compare the effectiveness of two dosing regimens of oral edaravone in subjects with amyotrophic lateral ...

  8. A Study to Evaluate Effectiveness of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH) - Mayo Clinic

    A Study to Evaluate Effectiveness of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH) · Overview · Participation eligibility · Participating Mayo ...

  9. Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS - Mayo Clinic

    This study will evaluate whether prolonged oral levosimendan can preserve respiratory function more effectively than placebo, resulting in better patient ...

  10. Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS - Mayo Clinic

    The purpose of this study is to confirm that levosimendan can significantly improve respiratory function measured by supine slow vital capacity (SVC) in ...